

Leadership
Jiyoung Jung
Jiyoung Jung joined SK Biopharmaceuticals Co., Ltd. in 2017 and currently serves as Vice President and Chief Finance Officer of SK Biopharmaceuticals and SK Life Science, Inc. With more than two decades of experience in finance across SK Group, Mr. Jung provides strategic financial leadership to support the company’s sustainable growth and global expansion. He also serves as an executive director of SK Biopharmaceuticals.
As CFO, Mr. Jung oversees the company’s finance organization, including financial planning and analysis, accounting and reporting, treasury, tax, internal controls, and capital allocation. He works closely with business leaders to strengthen financial discipline, manage risks, and align resources with the company’s strategic priorities.
Mr. Jung played a key role in SK Biopharmaceuticals’ successful initial public offering on the Korea Exchange in 2020, leading the company’s financial preparations and capital-markets strategy. Since the IPO, he has continued to strengthen the company’s financial foundation as it expands its global commercial business and invests in future growth.
Mr. Jung earned his bachelor’s degree in business administration from Korea University and a master’s degree from ESADE Business School in Spain.